| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | RBM13 |
| Uniprot No | Q9BXY0 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-300 aa |
| 活性数据 | MQSDDVIWDT LGNKQFCSFK IRTKTQSFCR NEYSLTGLCN RSSCPLANSQ YATIKEEKGQ CYLYMKVIER AAFPRRLWER VRLSKNYEKA LEQIDENLIY WPRFIRHKCK QRFTKITQYL IRIRKLTLKR QRKLVPLSKK VERREKRREE KALIAAQLDN AIEKELLERL KQDTYGDIYN FPIHAFDKAL EQQEAESDSS DTEEKDDDDD DEEDVGKREF VEDGEVDESD ISDFEDMDKL DASSDEDQDG KSSSEEEEEK ALSAKHKGKM PLRGPLQRKR AYVEIEYEQE TEPVAKAKTT |
| 分子量 | 35.3 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是模拟生成的关于重组人RBM13蛋白的3篇参考文献(非真实文献，仅供示例参考)：
1. **"RBM13 modulates mRNA splicing in hepatocellular carcinoma via interaction with U2AF65"**
- 作者: Zhang L, et al.
- 摘要: 研究揭示了RBM13通过与剪接因子U2AF65结合调控肝癌细胞中关键基因(如TP53和EGFR)的可变剪接，促进肿瘤侵袭性。
2. **"Structural insights into the RNA-binding domain of human RBM13 protein"**
- 作者: Patel S, et al.
- 摘要: 通过X射线晶体学解析RBM13的RNA结合结构域，发现其含有非典型RNA识别基序(RRM)，并验证了与富含GU序列的RNA结合能力。
3. **"RBM13 is a novel regulator of neuronal stress granule dynamics"**
- 作者: Kim M, et al.
- 摘要: 报道RBM13在神经细胞氧化应激反应中参与应激颗粒组装，调控TIA-1和G3BP1的定位，影响细胞存活通路。
注：以上文献为模拟创作，实际研究中RBM13相关文献较少。如需真实文献，建议在PubMed或Google Scholar检索关键词"RBM13 protein"并筛选最新研究。
**Background of RBM13 Protein**
Recombinant human RBM13 (RNA-binding motif protein 13) is a member of the RNA-binding protein family characterized by conserved RNA recognition motifs (RRMs). It plays a regulatory role in RNA metabolism, including pre-mRNA splicing, transport, stability, and translation. Structurally, RBM13 contains two RRM domains that mediate interactions with RNA or other proteins, along with a prion-like domain that may facilitate liquid-liquid phase separation, a process critical for forming membrane-less organelles involved in RNA processing.
RBM13 is implicated in diverse cellular processes, such as cell proliferation, differentiation, and stress responses. Studies suggest its involvement in carcinogenesis, where dysregulation of RBM13 expression correlates with tumor progression in cancers like hepatocellular carcinoma and colorectal cancer. It may act as an oncogene or tumor suppressor, depending on context, potentially via modulating splicing of cancer-related transcripts or interacting with non-coding RNAs.
Emerging evidence links RBM13 to neurological disorders, including amyotrophic lateral sclerosis (ALS), possibly due to aberrant RNA processing. Its role in viral infections, such as hepatitis C, has also been explored, highlighting interactions with viral RNA. Despite these findings, the precise molecular mechanisms and full spectrum of RBM13 functions remain understudied, warranting further research to unravel its therapeutic potential in disease contexts.
(Word count: 200)
×
